Kevin M. Lalande, Director at LUMOS PHARMA, INC. (LUMO), bought 31,062 shares at $9.87 ($314K) on 2021-08-25, disclosed to the SEC on 2021-08-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.87 | 14,900 | $147K | 46.8% |
| 2 | $10.07 | 6,200 | $62K | 19.9% |
| 3 | $10.50 | 4,981 | $52K | 16.7% |
| 4 | $10.50 | 4,981 | $52K | 16.7% |
| Total | $10.11 avg | 31,062 | $314K | 100% |
| Filing → |
| LUMO | BUY | 2021-09-07 | $274K | — | Filing → |
| LUMO | BUY | 2021-09-01 | $269K | — | Filing → |
| LUMO | BUY | 2021-08-24 | $1.2M | — | Filing → |